MITOMYCIN-C AND VINBLASTINE IN ADVANCED REFRACTORY BREAST-CANCER

被引：13
|
作者：
BRAMBILLA, C [1 ]
ZAMBETTI, M [1 ]
FERRARI, L [1 ]
BONADONNA, G [1 ]
机构：
[1] IST NAZL TUMORI,DIV MED ONCOL,VAI G VENEZIAN 1,I-20133 MILAN,ITALY
来源：
TUMORI | 1989年 / 75卷 / 02期
关键词：
D O I：
10.1177/030089168907500212
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141 / 144
页数：4
相关论文
共 50 条
  • [41] COMBINATION THERAPY OF PRETREATED PROGRESSIVE BREAST-CANCER WITH MITOMYCIN-C AND VINDESINE
    HOFFMANN, W
    BEISICHT, CU
    WEIDMANN, B
    NIEDERLE, N
    SEEBER, S
    TUMORDIAGNOSTIK & THERAPIE, 1991, 12 (03) : 102 - 105
  • [42] RESPONSE RATES AND TOXICITY OF MITOMYCIN-C, MITOXANTRONE, AND METHOTREXATE (3M) IN ADVANCED BREAST-CANCER
    PORZSOLT, F
    MEURET, G
    ONKOLOGIE, 1991, 14 (04): : 338 - 340
  • [43] A RANDOMIZED TRIAL OF MITOMYCIN-C (M) VERSUS MITOMYCIN-C PLUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MMPA) IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, G
    FALKSON, CB
    FALKSON, HC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (01): : 14 - 17
  • [44] FIXED DOSE SHORT COURSE MITOMYCIN-C WITH VINCRISTINE IN ADVANCED PRE-TREATED BREAST-CANCER
    MILLWARD, MJ
    HENDRICK, A
    CANTWELL, BMJ
    ANNALS OF ONCOLOGY, 1990, 1 (05) : 373 - 374
  • [45] HIGH-DOSE MEDROXYPROGESTERONE ACETATE PLUS MITOMYCIN-C OR VINDESINE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, HC
    FALKSON, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 431 - 434
  • [46] A PHASE-II STUDY OF COMBINED 5-FLUOROURACIL AND MITOMYCIN-C IN ADVANCED BREAST-CANCER
    MATTSSON, W
    VONEYBEN, F
    HALLSTEN, L
    BJELKENGREN, G
    CANCER, 1982, 49 (02) : 217 - 220
  • [47] MITOMYCIN-C, MITOXANTRONE (MX) AS 2ND LINE THERAPY FOR PATIENTS WITH ADVANCED BREAST-CANCER
    BISHOP, JF
    JEAL, PN
    HILLCOAT, BL
    RAGHAVAN, D
    COATES, A
    LEVI, J
    WOODS, R
    BURNS, I
    SNYDER, R
    MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (04): : 295 - 295
  • [48] MITOMYCIN-C IS AN INACTIVE DRUG IN THE 3RD-LINE TREATMENT OF HORMONE AND CHEMOTHERAPY REFRACTORY BREAST-CANCER
    DEES, A
    VERWEIJ, J
    VANPUTTEN, WLJ
    STOTER, G
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (09): : 1343 - 1347
  • [49] SURGICAL ADJUVANT CHEMOTHERAPY WITH MITOMYCIN-C AND CYCLOPHOSPHAMIDE IN JAPANESE PATIENTS WITH BREAST-CANCER
    KOYAMA, H
    WADA, T
    TAKAHASHI, Y
    NISHIZAWA, Y
    IWANAGA, T
    AOKI, Y
    TERASAWA, T
    KOSAKI, G
    KAJITA, A
    WADA, A
    CANCER, 1980, 46 (11) : 2373 - 2379
  • [50] MITOMYCIN-C, MELPHALAN AND METHOTREXATE COMBINATION CHEMOTHERAPY FOR PALLIATION OF DISSEMINATED BREAST-CANCER
    PEREZ, DJ
    POWLES, TJ
    GAZET, JC
    FORD, HT
    COOMBES, RC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (01) : 36 - 38
12345